Consecutive brain SPECT surface three-dimensional displays show progression of cerebral cortical abnormalities in Alzheimer's disease

Clinical Nuclear Medicine

Volumn 24, Issue 10, 1999, Pages 773-777

  Shih, Wei Jen ^a   Ashford, J Wesson ^b   Coupal, John J ^b   Ryo, Yun U ^b   Stipp, Vickie ^b   Magoun, Sylvia L ^b   Gross, Kelly ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Alzheimer's Disease; Brain SPECT; Mini Mental State Examination; Surface Three Dimensional Displays; Tc 99m Ethyl Cysteinate Dimer; Time Index

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN FUNCTION; DISEASE SEVERITY; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

EID: 0032841077     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199910000-00008     Document Type: Article

References (19)

1. Whitehouse PJ, ed: Dementia, Volume 40, Contemporary Neurology Series. Philadelphia: FA Davis, 1993.
2. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1:103, 1991.
3. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239, 1991.
4. Geldmacher DS, Whitehouse PJ: Evaluation of dementia. N Engl J Med 335:330, 1996.
5. Ashford JW, Shan M, Butler S, Rajasekear A, Schmitt FA: Temporal quantification of Alzheimer's disease severity: "Time index" model. Dementia 6:269, 1995.
6. Herholz K: FDG PET and differential diagnosis of dementia. Alz Dis Assoc Dis 9:6, 1995.
7. Burdette JH, Minoshima S, Borght TV, Tran DD, Kuhl DE: Alzheimer's disease: Improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 198:837, 1996.
8. Schmitt FA, Shih WJ, DeKosky ST: Neuropsychological correlates of SPECT in Alzheimer's disease. Neuropsychology 6:159, 1992.
9. Dewan MJ, Guptal S: Toward a definite diagnosis of Alzheimer's disease. Compr Psychiatry 33:282, 1992.
10. Holman BL, Nage JS, Johnson KA, et al: Imaging dementia with SPECT. Ann N Y Acad Sci 620:165, 1993.
11. Bonte FJ, Tinter R, Weiner MF, et al: Brain Blood flow in the dementia: SPECT with histopathologic correlation. Radiology 186:361, 1993.
12. Ishimura J, Fukuchi M: Clinical application of three-dimensional surface of display in brain imaging with Tc-99m HMPAO. Clin Nucl Med 16:343, 1991.
13. Okuda B, Tachibana H, Kabana K, et al: Three dimensional displays with I-123 IMP of slowly progressive apraxia. Clin Nucl Med 18:85, 1993.
14. Shih WJ, Hyatt M: Volume and surface three-dimensional displays of Tc-99m HMPAO brain SPECT imaging in a chronic hypnosedative abuser. Clin Nucl Med 18:506, 1993.
15. McKhann C, Drachman D, Folstein M, et al: Clinical Diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939, 1984.
16. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189, 1975.
17. Fox NC, Freeborough PA, Rossor MN: Visualization and quantification of rate of atrophy in Alzheimer's disease. Lancet 384: 94, 1996.
18. Song WZ, Chen M, Chen CG, et al: SPECT cerebral flow imaging in normal neonates. Chin J Nucl Med 17:160, 1997.
19. Focrele DS, Baumann RJ, Shih WJ, et al: Tc-99m HMPAO SPECT of brain in the neonate. Clin Nucl Med 15:175, 1990.